Viewing StudyNCT00062660

Home Icon Home Search Icon Search Alerts Icon Stocks Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs eRecord Icon eRecord
Main Search All Studies All Organizations Report Bug
View Study With Definitions
Ignite Creation Date: 2024-05-05 @ 11:30 AM
Last Modification Date: 2024-10-26 @ 9:08 AM
Study NCT ID: NCT00062660
Status: APPROVED_FOR_MARKETING
Last Update Posted: 2016-11-30
First Post: 2003-06-10
Brief Title: Tipranavir in Patients With Progressive Systemic HIV-1 Disease Who Have Failed or Are Intolerant to Currently Approved Treatments for HIV Infection
Sponsor: Boehringer Ingelheim
Organization: Boehringer Ingelheim
Overview Dates Organization Conditions Design Enrollment Locations Outcomes

Conditions & Keywords Data

Conditions:
Name
HIV Infections
Keywords: